H2020Докторантска мрежа2015–2019

REP-BIOTECH · European Joint Doctorate in Biology and Technology of Reproductive Health

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2015-11-01 → 2019-10-31
Финансиране от ЕС
3 811 469 €
Участници
15
Схема
MSCA-ITN-EJD

Линиите свързват координатора с партньорите.

Накратко на български

Механизмите на оплождането и развитието на ембрионите при бозайниците се изучават чрез търсене на молекули, отговорни за успешното зачеване. Това помага за подобряване на качеството на храните, диагностиката на репродуктивни проблеми и лечението на заболявания при хора и животни.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

European Joint Doctorate in Biology and Technology of Reproductive Health

Rep-Biotech is an Innovative Training Network composed of 12 leading academic research groups and 3 companies from 9 different countries: Spain, France, Ireland, Italy, Belgium, Germany, USA, Japan and The Netherlands. Rep-Biotech aimed to deepen the basic knowledge of the mechanisms involved in mammalian fertilization and embryo development, providing useful strategies contributing towards improved food quality (through the implementation of more efficient and secure animal reproductive technologies), human health (by contributing to finding solutions to reproductive pathologies and their epidemiologic factors) and human and animal fertility (by identifying target molecules involved in successful fertilization). The overall objective of Rep-Biotech was to build a research, training and academic programme to train a new generation of creative, entrepreneurial and innovative Early-Stage Researchers (ESRs) in the interdisciplinary domain of reproductive health and fertility. To achieve this overall objective, 8 Work Packages (WPs) were specifically designed. Our main conclusions are: - the novelty of the different results obtained indicates that we have produced relevant information with potential applications to improve the diagnosis and treatments of different reproductive issues. - the inclusion of partner organizations from the industry sector in the doctoral/research training programme favours the development of application-oriented research projects and widens the employability of the ESRs outside the traditional academic sector. - the project has consolidated a Joint Doctoral degree structure that will continue training more PhD candidates.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

The main objective of the European Doctorate in Biology and Technology of the Reproductive Health (REP-BIOTECH) is to build a research, training and academic programme in the interdisciplinary domain of reproductive health and fertility. Basic knowledge of mechanisms involved in mammalian fertilization and embryo development provides useful strategies to improve food quality (by implementation of efficient and secure animal reproductive technologies), human health (by contributing to the control of reproductive diseases and epidemiologic factors) and human and animal fertility (by identifying target molecules for successful conception or contraception).REP-BIOTECH is a PhD programme with the aim of training a new generation of creative, entrepreneurial and innovative Early-Stage Researchers (ESRs). ESRs must carry out independent research on a specific topic to be awarded a European Joint Degree from 5 European Universities (Beneficiaries). The PhD project will be jointly supervised within a joint governance structure in which the beneficiaries as well as the partner organisations will be actively involved. The Doctorate programme will expose ESRs to different sectors and they will acquire a comprehensive set of transferable skills working in the specific research area relating to their doctoral thesis.The consortium has a proven track record in their area and they have a history of fruitful scientific collaboration. Moreover, giving the diversity amongst the participating institutions, the ESRs will be able to face current and future challenges in order to convert knowledge and ideas into products and services for economic and social benefit. The strength of the partnership lies in being a multidisciplinary group (animal and human fertility, reproductive health and reproductive technologies) within the cooperation of 7 different European countries, the collaboration of Universities from Japan and United States and partners from the non academic sector.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз